Metabolic dysfunction-associated steatotic liver disease (MASLD), including metabolic dysfunction-associated steatohepatitis (MASH), is the most common aetiology of liver disease worldwide. MASLD is ...

Evidence tells us that a treatable traits intervention will improve quality of life for people with chronic obstructive ...

Law enforcement agencies are still investigating a gunman's August 8 attack on the headquarters of the US Centers for Disease ...

There are approximately 500 000 new cases of rifampicin-resistant or multidrug-resistant (RR/MDR) tuberculosis every year. In 2022, WHO recommended the all-oral bedaquiline, pretomanid, linezolid ...

Meru Sheel probably grew up in one of the most pro-women homes in New Delhi, India, with both her parents involved in women's advocacy and her father working in girls’ and women's education. “We would ...

The emergence of the COVID-19 pandemic in 2020 shed a light on, and exacerbated, many health inequalities that were in some ways obscured from the gaze of the global population. The disproportionate ...

Mexico's COVID-19 “fiasco was avoidable”, writes Thomas Legler in The politics of COVID-19 in Mexico: governance meets government. Ranked fifth in the world for the number of deaths, Mexico's COVID-19 ...

Not many people are better equipped to dissect the food system than Stuart Gillespie. He has spent the past four decades ...

Power imbalances persist in research, prioritising the experience and knowledge of those with social, political, and economic power while silencing or misrepresenting others. This dynamic—which is ...

Synthetic nicotine analogues are a new class of compounds making their way into the European and US vaping markets, raising urgent questions about public health, regulation, and scientific research.1 ...

Humans are programmed to follow intellectual fashions. In the field of chronic obstructive pulmonary disease (COPD), the concept that inflammation is the core problem is dominant, whereas other key ...

The Review by Stefanie Deinhardt-Emmer and colleagues1 on sepsis in patients who are immunocompromised is comprehensive and addresses a key and complex population. However, we would like to express ...